Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded promising developments into new therapeutic approaches. Current research centers on addressing the underlying causes of MSA. One avenue under investigation involves pharmacological interventions to influence the dysregulatio